A new generation of highly predictive biomarkers are being developed and launched to revolutionise the diagnosis and prognosis of cancer. Candesic’s Dr Chris Cassar and…
Reshaping cancer diagnosis and care pathways in the UK
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
